OJJAARA (MOMELOTINIB DIHYDROCHLORIDE) — FDA Approval NDA216873 (GLAXOSMITHKLINE)
OJJAARA (MOMELOTINIB DIHYDROCHLORIDE) — FDA Approval NDA216873 (GLAXOSMITHKLINE) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: OJJAARA; Active ingredients: MOMELOTINIB DIHYDROCHLORIDE; Application number: NDA216873.
| Brand name | OJJAARA |
|---|---|
| Active ingredients | MOMELOTINIB DIHYDROCHLORIDE |
| Application number | NDA216873 |
| Sponsor | GLAXOSMITHKLINE |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 3 |
| First approval date | 20230915 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →